1,087 results on '"Horninger, Wolfgang"'
Search Results
2. Subsets of preoperative sex hormones in testicular germ cell cancer: a retrospective multicenter study
3. Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response
4. Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study
5. Sonographie der Prostata und des äußeren Genitales
6. Nuklearmedizin der Prostata und des äußeren Genitale
7. MRT der Prostata
8. Sonographie der Prostata und des äußeren Genitales
9. Do we need repeated CT imaging in uncomplicated blunt renal injuries? Experiences of a high-volume urological trauma centre
10. Glycoprofiling of proteins as prostate cancer biomarkers: A multinational population study
11. Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma
12. Sonographie der Prostata und des äußeren Genitales
13. Amplification of 7p12 Is Associated with Pathologic Nonresponse to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
14. Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [68Ga]Ga-PSMA-11-PET/CT in the evaluation of prostate cancer patients
15. The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
16. Real-world evidence of triplet therapy in metastatic hormone-sensitive prostate cancer - an Austrian multicenter study
17. Nanoparticle-Based Bio-Barcode Assay Redefines “Undetectable” PSA and Biochemical Recurrence after Radical Prostatectomy*
18. Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients
19. The impact of surgery in oligometastatic prostate cancer
20. Lutetium-PSMA therapy—a new therapeutic option in metastatic castration-resistant prostate cancer?
21. ASCO 2018: highlights of urothelial cancer and prostate cancer
22. Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study
23. Sonographie der Prostata und des äußeren Genitales
24. Effect of Urinary Cytology for Detecting Recurrence in Remnant Urothelium After Radical Cystectomy: Insights From a 10-year Cytology Database
25. Pelvic Lymph Node Staging by Combined 18F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy
26. Incidental resection of a scrotal aggressive angiomyxoma mimicking a spermatocele: a case report
27. Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy
28. Supplementary Tables 1-2, Supplementary Figures 1-2 from Genetic Variation of Genes Involved in Dihydrotestosterone Metabolism and the Risk of Prostate Cancer
29. Early PET imaging with [68]Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence
30. 68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour
31. Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions
32. The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates
33. Retropubic Radical Prostatectomy: The Results
34. Correction to: The 68Ga/177Lu-theragnostic concept in PSMA-targeting of metastatic castration–resistant prostate cancer: impact of post-therapeutic whole-body scintigraphy in the follow-up
35. Real-world comparison of Docetaxel versus new hormonal agents in combination with androgen-deprivation therapy in metastatic hormone-sensitive prostate cancer descrying PSA Nadir ≤ 0.05 ng/ml as marker for treatment response
36. Increased accuracy of a novel mRNA‐based urine test for bladder cancer surveillance
37. Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot
38. Optilume® drug-coated balloon dilation in complex female urethral stricture
39. Paratesticular Metastasis of a Clear-Cell Renal-Cell Carcinoma With Renal Vein Thrombus Mimicking Primary Testicular Cancer
40. 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
41. Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis
42. Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk
43. Nanoparticle-Based Bio-Barcode Assay Redefines "Undetectable" PSA and Biochemical Recurrence after Radical Prostatectomy
44. Effects of cycling and rowing on serum concentrations of prostate‐specific antigen: A randomized study of 101 male subjects
45. Optilume® drug-coated balloon dilation in complex female urethral stricture
46. Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer
47. Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men?
48. Organ-sparing surgery is the treatment of choice in benign testicular tumors
49. Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group
50. Prevalence of the human papillomavirus (HPV) expression of the inner prepuce in asymptomatic boys and men
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.